Justin N Huard

age ~42

from Seattle, WA

Get Report

Connected to:

Justin Huard Phones & Addresses

8031 28Th Ave NW, Seattle, WA 98117 • 2067890672
931 86Th St, Seattle, WA 98103 • 2067296817
Everett, WA

Work

Company:

Novo nordisk
Jun 2017
Position:

Senior associate scientist

Education

Degree:

Bachelors, Bachelor of Arts
School / High School:

University of Washington
2003

Skills

Drug Discovery • Biotechnology • Cell Culture • Assay Development • Elisa • Immunology • Cell • Monoclonal Antibodies • Antibodies • Cell Biology • In Vivo • Western Blotting • Flow Cytometry • Immunoassays • Facs • Biomarkers • In Vivo Imaging • Apoptosis • Life Sciences • Innovation • Teamwork • Tumor Modeling • Cell Based Assays

Industries

Biotechnology

Us Patents

Fused Tricyclic Dual Inhibitors Of Cdk 4/6 And Flt3
view source
US Patent:

20120244110, Sep 27, 2012
Filed:

Mar 21, 2012
Appl. No.:

13/425817
Inventors:

Xiaoqi Chen - Palo Alto CA, US
Kang Dai - Albany CA, US
Jason Duquette - South San Francisco CA, US
Justin N. Huard - Seattle WA, US
Kathleen S. Keegan - Bainbridge Island WA, US
Zhihong Li - Millbrae CA, US
Sarah E. Lively - San Carlos CA, US
Lawrence R. McGee - Pacifica CA, US
Mark L. Ragains - Fort Worth TX, US
Xianghong Wang - Dublin CA, US
Margaret F. Weidner - Woodinville WA, US
Jian Zhang - Foster City CA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 31/519
A61K 31/7068
A61K 31/704
A61P 35/02
A61K 31/573
A61K 39/395
A61K 38/19
A61P 35/00
C07D 471/14
A61K 31/664
US Classification:

424 851, 544251, 514267, 514 49, 514 34, 514110, 514171, 4241331, 4241421, 4241721, 4241361
Abstract:

Compounds of Formula I are useful inhibitors of CDK 4, CDK6, and FLT3. Such compounds are useful in treating cancer and various other disease conditions. Compounds of Formula I have the following structure:and the definitions of the other variables are provided herein.

Fused Tricyclic Dual Inhibitors Of Cdk 4/6 And Flt3
view source
US Patent:

20160368933, Dec 22, 2016
Filed:

Apr 22, 2016
Appl. No.:

15/136716
Inventors:

- THOUSAND OAKS CA, US
Kang DAI - Albany CA, US
Jason DUQUETTE - Millbrae CA, US
Justin N. HUARD - Seattle WA, US
Kathleen S. KEEGAN - Bainbridge Island WA, US
Zhihong LI - Millbrae CA, US
Sarah E. LIVELY - San Carlos CA, US
Lawrence R. MCGEE - Pacifica CA, US
Mark L. RAGAINS - Forth Worth TX, US
Xianghong WANG - Dublin CA, US
Margaret F. WEIDNER - Woodinville WA, US
Jian ZHANG - Foster City CA, US
International Classification:

C07D 519/00
Abstract:

Compounds of Formula I are useful inhibitors of CDK 4, CDK6, and FLT3. Such compounds are useful in treating cancer and various other disease conditions. Compounds of Formula I have the following structure:and the definitions of the other variables are provided herein.

Resumes

Senior Associate Scientist

view source

Location:

Seattle, WA

Industry:

Biotechnology

Work:

Novo Nordisk
Senior Associate Scientist
Novo Nordisk May 2015 - Jun 2017
Associate Scientist
Amgen Mar 2011 - Dec 2014
Senior Associate Scientist
Amgen Mar 2008 - Mar 2011
Associate Scientist
Amgen Sep 2005 - Mar 2008
Senior Associate

Education:

University of Washington 2003
Bachelors, Bachelor of Arts University of Washington 1999 - 2003
Bachelors, Bachelor of Science, Biochemistry

Skills:

Drug Discovery
Biotechnology
Cell Culture
Assay Development
Elisa
Immunology
Cell
Monoclonal Antibodies
Antibodies
Cell Biology
In Vivo
Western Blotting
Flow Cytometry
Immunoassays
Facs
Biomarkers
In Vivo Imaging
Apoptosis
Life Sciences
Innovation
Teamwork
Tumor Modeling
Cell Based Assays